Bank of the West’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-2,020
Closed -$216K – 306
2017
Q4
$216K Buy
+2,020
New +$216K 0.03% 278
2015
Q3
– Sell
-1,710
Closed -$210K – 285
2015
Q2
$210K Sell
1,710
-210
-11% -$25.1K 0.03% 275
2015
Q1
$220K Buy
+1,920
New +$212K 0.03% 267
2014
Q3
– Sell
-2,505
Closed -$215K – 262
2014
Q2
$215K Buy
+2,505
New +$197K 0.03% 243

Other funds holding IBB

Bank of the West's IBB Position: Q1 2018 in Review

Bank of the West sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 2,020 shares — an estimated $216K sold.

Bank of the West first reported a position in IBB in Q2 2014 and held it in 4 quarters. The position peaked at $220K in Q1 2015. 607 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

  • Bank of the West reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
  • Bank of the West sold 2,020 iShares Biotechnology ETF shares in Q1 2018, an estimated $216K.
  • Bank of the West first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 4 quarters.
  • Bank of the West's iShares Biotechnology ETF position peaked at $220K in Q1 2015.
  • 607 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Bank of the West's 13F filing for Q1 2018, filed 8 May 2018.